Cargando…
Overexpression of miR-106a enhances oxaliplatin sensitivity of colorectal cancer through regulation of FOXQ1
Chemotherapy resistance poses a major challenge for the clinical treatment of colorectal cancer, therefore, the aim of the present study was to examine its underlying mechanisms. Reverse transcription-quantitative polymerase chain reaction and western blot analysis were used to determine the microRN...
Autores principales: | Liu, Zhihu, Qin, Yan, Dong, Shuxiao, Chen, Xiao, Huo, Zhibin, Zhen, Zhongguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924180/ https://www.ncbi.nlm.nih.gov/pubmed/31897182 http://dx.doi.org/10.3892/ol.2019.11151 |
Ejemplares similares
-
miR-106a Reduces 5-Fluorouracil (5-FU) Sensitivity of Colorectal Cancer by Targeting Dual-Specificity Phosphatases 2 (DUSP2)
por: Qin, Yan, et al.
Publicado: (2018) -
Overexpressed GATA3 enhances the sensitivity of colorectal cancer cells to oxaliplatin through regulating MiR-29b
por: Wang, Wei, et al.
Publicado: (2020) -
MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma
por: Peng, Xiao Hong, et al.
Publicado: (2014) -
MiR-506 Suppresses Tumor Proliferation and Invasion by Targeting FOXQ1 in Nasopharyngeal Carcinoma
por: Zhang, Zhanchi, et al.
Publicado: (2015) -
Diagnostic and prognostic value of miR-106a in colorectal cancer
por: Hao, Haibin, et al.
Publicado: (2016)